Accessibility Menu
Covalon Technologies logo

Covalon Technologies(TSXV) COV

Current PriceCA$2.15
Market CapCA$58.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)-25%
5 Year+51%
1 Year-13%
1 Month-6%
Covalon Technologies last closing stock price
MetricPriceDate
Last closeCAD 2.102026-07-22
Covalon Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.44%CAD 2.052026-07-15
1 month-5.83%CAD 2.232026-06-22
3 month+10.53%CAD 1.902026-04-23
Year to date+20.69%CAD 1.742025-12-31
1 year-13.46%CAD 2.432025-07-22
3 year+23.63%CAD 1.702023-07-20
5 year+51.01%CAD 1.392021-07-23
Since inception-25%CAD 2.802004-09-03

Covalon Technologies Financials at a Glance

Market Cap

CA$58.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$32.68M

Net Income (TTM)

CA$1.64M

EPS (TTM)

CA$0.06

P/E Ratio

35.23

Dividend

CA$0.00

Beta (Volatility)

0.20 (Low)

Price

CA$2.15

Volume

10,401

Open

CA$2.15

Previous Close

CA$2.10

Daily Range

CA$2.15 - CA$2.15

52-Week Range

CA$1.55 - CA$2.89

Estimated Earnings Date

Aug 20, 2026

COV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Covalon Technologies

Covalon Technologies Ltd. is a Canadian biotechnology company based in Mississauga, specializing in the innovation, development, manufacturing, and commercialization of advanced medical technologies and products. The company operates in major international markets, leveraging proprietary technology platforms to address various healthcare needs.

Products and Services
  • Advanced wound care dressings for chronic and infected wounds
  • Antimicrobial silicone adhesive products for surgical and vascular access
  • Unique medical coatings for enhancing existing medical devices
Growth Outlook
  • Recent quarterly revenue reached CAD 8.73 million, a significant increase
  • Trailing twelve months (TTM) revenue shows a growth trend with CAD 34.5 million
  • Strong international market presence supports future expansion opportunities
Financial Highlights
  • Net income for the latest quarter was CAD 1.09 million, reflecting profitability
  • TTM gross profit margin stands at 52.96%, indicating operational efficiency
  • Current ratio of 7.57 suggests strong liquidity and financial health
Covalon Technologies Ltd. is positioned in the healthcare sector, focusing on innovative solutions that cater to a diverse clientele, including hospitals and specialized care facilities. The company's proprietary technology platforms enhance its product offerings, making them competitive in the global market. Recent financial performance indicates a positive trajectory, with increasing revenues and profitability, which may attract potential investors looking for opportunities in the biotechnology industry. The strong liquidity position further underscores the company's ability to navigate market challenges and invest in future growth.
AI Generated • Jul 3, 2026

Industry

Biotechnology

Sector

Health Care

CEO

Brent Ashton

Website

www.covalon.com

Headquarters

Mississauga, ON L4W 5S7, CA

COV Financials

Key Financial Metrics (TTM)

Gross Margin

52.96%

Operating Margin

3.49%

Net Income Margin

5.02%

Return on Equity

5.72%

Return on Capital

5.35%

Return on Assets

4.95%

Earnings Yield

2.84%

Dividend Yield

0.00%

Payout Ratio

2.52%

Stock Overview

Market Cap

CA$58.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

27.62M

Volume

10.40K

Avg. Volume

9.09K

Financials (TTM)

Gross Profit

CA$17.31M

Operating Income

CA$1.14M

EBITDA

CA$2.09M

Operating Cash Flow

CA$6.09M

Capital Expenditure

-CA$1.42M

Free Cash Flow

CA$4.67M

Cash & ST Invst.

CA$16.57M

Total Debt

CA$1.77M

Covalon Technologies Performance Analysis

Covalon Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30CAD 18,146,390-7.2%
20232023-09-30CAD 26,595,28646.6%
20242024-09-30CAD 31,168,53217.2%
20252025-09-30CAD 32,816,3475.3%
Covalon Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-3010.4%
Q42025-09-303.8%
Q12025-12-31-20.8%
Q22026-03-3126.7%
Covalon Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30CAD -0.38N/A
20232023-09-30CAD -0.18-52.2%
20242024-09-30CAD 0.11N/A
20252025-09-30CAD 0.07-31.0%
Covalon Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-85.1%
Q42025-09-30469.6%
Q12025-12-31-65.6%
Q22026-03-31775.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$8.73M

+15.0%

Gross Profit

CA$5.16M

+24.7%

Gross Margin

59.14%

N/A

Market Cap

CA$58.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$552.36K

N/A

Employees

105

N/A

Net Income

CA$1.09M

+154.8%

EBITDA

CA$1.16M

+125.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$16.57M

-8.1%

Total Debt

CA$1.77M

+191.0%

Accounts Receivable

CA$4.70M

-6.4%

Inventory

CA$6.38M

-28.6%

Long Term Debt

CA$1.44M

+1206.3%

Short Term Debt

CA$332.03K

-66.7%

Return on Assets

4.95%

N/A

Return on Invested Capital

3.87%

N/A

Free Cash Flow

-CA$1.36M

-311.8%

Operating Cash Flow

-CA$1.15M

-270.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SVA.TOSernova Corp.
CA$0.12+0.00%
MIR.VMedMira Inc.
CA$0.06-14.29%
MBX.TOMicrobix Biosystems Inc.
CA$0.30-3.23%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.88-0.28%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.16+0.05%
HBANHuntington Bancshares
$17.38-0.05%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$37.03+0.08%

Questions About COV

What is the current price of Covalon Technologies?

Covalon Technologies is trading at CA$2.15 per share.

What is the 52-week range for Covalon Technologies?

Over the past 52 weeks, Covalon Technologies has traded between CA$1.55 and CA$2.89.

How much debt does Covalon Technologies have?

As of the most recent reporting period, Covalon Technologies reported total debt of CA$1.77M.

How much cash does Covalon Technologies have on hand?

Covalon Technologies reported CA$16.57M in cash and cash equivalents in its most recent financial results.

What is Covalon Technologies’s dividend yield?

Covalon Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services